Clovis Oncology

Clovis Oncology buys Ethical Oncology Science and says it will pay $200M upfront
Yahoo/AP
Wed, 11/20/13 - 08:36 am
Ethical Oncology Science
M&A
Clovis Oncology
Clovis Oncology's CEO Discusses Q3 2013 Results - Earnings Call Transcript
Seeking Alpha
Fri, 11/1/13 - 08:22 am
earnings
Clovis Oncology
Clovis, Synta, and Incyte Could Be Big Movers Today
Motley Fool
Tue, 10/29/13 - 09:42 am
Clovis Oncology
Synta
Incyte
CO-1686
non-small cell lung cancer
ganetespib
INCB39110
rheumatoid arthritis
4 Healthcare Stock Stories Getting Noticed on Monday
Wall St. Cheat Sheet
Mon, 10/28/13 - 07:46 pm
Merck
Teva
Clovis Oncology
Illumina
With Promising Results, AstraZeneca Targets Mutated Lung Cancer And Rival Clovis Drug
TheStreet.com
Mon, 09/30/13 - 10:31 am
AZD9291
Clovis Oncology
AstraZeneca
CO-1686
non-small cell lung cancer
Ongoing Phase I Monotherapy Study of Rucaparib in Patients with Solid Tumors Demonstrates Clinical Activity, Establishes Dose and Schedule
Yahoo/BusinessWire
Sun, 09/29/13 - 01:30 pm
Clovis Oncology
ovarian cancer
rucaparib
solid tumors
3 Signs We Could Be Entering a Biotech Bubble
Motley Fool
Sat, 09/28/13 - 01:09 pm
biotech
Perrigo
Bristol-Myers Squibb
Elan
Clovis Oncology
IPOs
Stemline
Amgen
Biogen Idec
ONYX Pharmaceuticals
Does a Lack of Interest Tell You This Biotech Has Limited Upside?
Motley Fool
Sat, 09/28/13 - 11:54 am
Clovis Oncology
Clovis Is Said to Get No Interest After Seeking Buyers
Bloomberg
Tue, 09/24/13 - 06:03 pm
Clovis Oncology
M&A
Is this Cancer-Fighting Biotech for Sale?
Motley Fool
Sun, 09/22/13 - 11:31 am
Clovis Oncology
5 Experimental Drugs That Could Make a Big Difference in Treating Lung Cancer
Motley Fool
Sun, 09/22/13 - 11:23 am
LDK378
Novartis
bavituximab
Peregrine Pharmaceuticals
nivolumab
Bristol-Myers Squibb
lambrolizumab
Merck
lung cancer
CO-1686
Clovis Oncology
Clovis Oncology Said to Explore Sale of Biotech Company
Bloomberg
Tue, 09/17/13 - 04:37 pm
Clovis Oncology
M&A
The Best- And Worst-Performing Biotech Stocks, June 28 to July 5
Forbes
Mon, 07/8/13 - 11:02 am
biotech
ONYX Pharmaceuticals
Celldex
Novavax
Puma Biotechnology
Endocyte
Alnylam
Bluebird Bio
Dyax
Medivation
Clovis Oncology
Achillion
Insmed
Arena Pharmaceuticals
Avanir
Receptos
Synergy Pharmaceuticals
ChemoCentryx
Idenix
MiMedx
Portola Pharmaceuticals
Clovis / CO-1686: Value, Derived From Data, Supports The Valuation
Seeking Alpha
Wed, 06/12/13 - 09:07 am
CO-1686
Clovis Oncology
non-small cell lung cancer
Five Best-Performing Biotech Stocks of 2013 (Some May Surprise You)
TheStreet.com
Tue, 06/11/13 - 10:14 am
Acadia
Clovis Oncology
MannKind
Chelsea Therapeutics
Keryx
ASCO Stocks That Should Sizzle in the Future
Motley Fool
Mon, 06/10/13 - 10:12 am
ASCO
Merck
Clovis Oncology
Bristol-Myers Squibb
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 06/8/13 - 10:15 am
Clovis Oncology
Tesaro
Acadia
Allergan
Clovis Oncology Skyrockets After ASCO Presentations
Seeking Alpha
Tue, 06/4/13 - 12:28 pm
ASCO
Clovis Oncology
CO-1686
rucaparib
Clovis Oncology Shares Almost Double on Cancer Drug Trial
Bloomberg
Mon, 06/3/13 - 12:38 pm
Clovis Oncology
rucaparib
ovarian cancer
3 Humongous Health-Care Stocks This Week
Motley Fool
Sat, 03/2/13 - 03:54 pm
Clovis Oncology
Orexigen
Optimer Pharmaceuticals

Pages